BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gennaro N, Marrari A, Renne SL, Cananzi FCM, Quagliuolo VL, Di Brina L, Scorsetti M, Pepe G, Chiti A, Santoro A, Balzarini L, Politi LS, Bertuzzi AF. Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging. Br J Radiol 2020;93:20200250. [PMID: 32559113 DOI: 10.1259/bjr.20200250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Gallego S, Bernabeu D, Garrido-Pontnou M, Guillen G, Hindi N, Juan-Ribelles A, Márquez C, Mata C, Orcajo J, Ramírez G, Ramos M, Romagosa C, Ruano D, Rubio P, Vergés R, Valverde C; GEIS (Grupo Español de Investigación en Sarcomas), SEHOP (Sociedad Española de Hematología y Oncología Pediátrica). GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma. Clin Transl Oncol 2021. [PMID: 34212338 DOI: 10.1007/s12094-021-02654-1] [Reference Citation Analysis]
2 Harrison DJ, Chi YY, Tian J, Hingorani P, Mascarenhas L, McCowage GB, Weigel BJ, Venkatramani R, Wolden SL, Yock TI, Rodeberg DA, Hayes-Jordan AA, Teot LA, Spunt SL, Meyer WH, Hawkins DS, Shulkin BL, Parisi MT. Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer Med 2021;10:857-66. [PMID: 33340280 DOI: 10.1002/cam4.3667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Gennaro N, Reijers S, Bruining A, Messiou C, Haas R, Colombo P, Bodalal Z, Beets-Tan R, van Houdt W, van der Graaf WTA. Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand? Crit Rev Oncol Hematol 2021;160:103309. [PMID: 33757836 DOI: 10.1016/j.critrevonc.2021.103309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu Z, Cheng T, Düwel S, Jian Z, Topping GJ, Steiger K, Wang Q, Braren R, Reder S, Mittelhäuser M, Hundshammer C, Feuerecker B, Huang SC, Schwaiger M, Schilling F, Ziegler SI, Shi K. Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigation. Eur J Nucl Med Mol Imaging 2021. [PMID: 34651225 DOI: 10.1007/s00259-021-05574-y] [Reference Citation Analysis]
5 Koerber SA, Finck R, Dendl K, Uhl M, Lindner T, Kratochwil C, Röhrich M, Rathke H, Ungerechts G, Adeberg S, Herfarth K, Jaeger D, Debus J, Haberkorn U, Giesel FL. Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT. Eur J Nucl Med Mol Imaging 2021. [PMID: 34018010 DOI: 10.1007/s00259-021-05374-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]